Immuneed
Uppsala
About Immuneed
Immuneed originated in research at Uppsala University. The company is developing a new generation of prostate cancer vaccines, based on activation of the body's own immune system against tumor cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $504.3K
- Funding stage: Seed
- Last round: Seed (Sep 2016)
- Website: immuneed.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/immuneed-174567 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.